This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The $3,111.10 fixed-price contract with economic price adjustment is for the delivery of OSTEOCEL PRO, a spinal fusion product, with a period of performance through October 4, 2024.
Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and operates as a for-profit organization. The company has an established history of providing specialized medical technologies, including spinal implants, instruments, biologics, and related surgical equipment, to the Department of Defense (DoD), Department of Veterans Affairs (VA), and Defense Health Agency (DHA). This contract award does not have a set-aside designation, indicating Nuvasive's strong competitive position in the federal medical device market. The company holds a notable $8 million Blanket Purchase Agreement (BPA) with the DHA, which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle for efficient access to Nuvasive's portfolio of spinal medical devices and instruments.
Generated 2/7/25, 9:22 AM